Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Neurology
  4. Targeting spinal mechanistic target of rapamycin complex 2 alleviates inflammatory and neuropathic pain

Targeting spinal mechanistic target of rapamycin complex 2 alleviates inflammatory and neuropathic pain

BRAIN, 2025 · DOI: 10.1093/brain/awae275 · Published: August 21, 2024

NeurologyPain ManagementGenetics

Simple Explanation

Chronic pain involves changes in spinal nociceptive circuits. The mechanistic target of rapamycin complex 2 (mTORC2) modulates structural changes and mRNA translation. Activation of spinal mTORC2 induces pain hypersensitivity. Inhibiting it, using Rictor downregulation, alleviates inflammatory and neuropathic pain. Inhibiting mTORC2 in specific excitatory neurons impairs spinal synaptic potentiation. This alleviates inflammation-induced mechanical and thermal hypersensitivity and nerve injury-induced heat hyperalgesia.

Study Duration
Not specified
Participants
8- to 12-week-old male and female C57BL/6 mice
Evidence Level
Not specified

Key Findings

  • 1
    Pharmacological activation of spinal mTORC2 induces pain hypersensitivity.
  • 2
    Inhibition of mTORC2, via Rictor downregulation, alleviates both inflammatory and neuropathic pain.
  • 3
    Selective mTORC2 inhibition in excitatory neurons alleviates inflammation-induced mechanical/thermal hypersensitivity and nerve injury-induced heat hyperalgesia.

Research Summary

This study investigates the role of spinal mTORC2 in inflammatory and neuropathic pain. Activation of mTORC2 induces pain hypersensitivity, while inhibition alleviates both types of pain. Cell type-specific deletion of Rictor reveals that mTORC2 in excitatory neurons mediates inflammation-induced and nerve injury-induced hypersensitivity. Conversely, mTORC2 ablation in inhibitory interneurons reduces nerve injury-induced mechanical hypersensitivity. The findings suggest spinal mTORC2 as a therapeutic target for chronic pain, highlighting its cell type-specific functions in pain hypersensitivity.

Practical Implications

Therapeutic Target

Spinal mTORC2 is a potential therapeutic target for chronic pain.

Cell Type Specificity

Targeting mTORC2 should consider the specific cell types involved in different pain conditions.

ASO Potential

Antisense oligonucleotides (ASOs) targeting mTORC2 could be an efficacious therapeutic strategy.

Study Limitations

  • 1
    Contribution of supraspinal brain areas cannot be ruled out.
  • 2
    Effects on neuronal output (excitability, synaptic transmission) haven't been investigated.
  • 3
    The role of mTORC2 in non-neuronal cells in chronic pain remains to be determined.

Your Feedback

Was this summary helpful?

Back to Neurology